Skip to content

Osteopathic Treatment in Adult Patients With Cystic Fibrosis

Impact of an Osteopathic Manipulative Treatment on Pain of Adult Patients With Cystic Fibrosis - a Pilot Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01293019
Acronym
MUCOSTEO
Enrollment
32
Registered
2011-02-10
Start date
2009-11-30
Completion date
2011-12-31
Last updated
2012-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis, Back Pain, Neck Pain, Chest Pain

Keywords

Complementary and alternative medicine, Osteopathic treatment

Brief summary

To study the contribution of osteopathy on the reduction of pain in adult patients with cystic fibrosis

Detailed description

To compare the impact of osteopathic treatment to a placebo of osteopathic treatment and to usual care on pain at 6 months in adult patient with cystic fibrosis localized to chest, cervical, dorsal neck or back.

Interventions

Real treatment of osteopathy

PROCEDURESham Placebo

Sham treatment of osteopathy

PROCEDUREUsual care

Classical treatment of pain in cystic fibrosis patients

Sponsors

Vaincre la Mucoviscidose
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

: * Diagnosis of cystic fibrosis ( positive sweat test and / or presence of 2 disease causing mutations in the CFTR gene * Age \> 18 years * Patient with chronic chest , neck or back pain * Written Informed Consent * with health insurance

Exclusion criteria

: * regular follow-up by an osteopathic physician in the previous 3 months * patients awaiting lung transplantation * history of lung transplantation * pregnancy * understanding disorders preventing the patient to apply the study * participation in another clinical interventional study protocol

Design outcomes

Primary

MeasureTime frame
Pain scoreat 6 months

Secondary

MeasureTime frame
quality of life scoresat 6 months
Co-interventionsat 6 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026